Hospital Consultations in Hyponatremia: Appropriate Diagnosis and Effective Treatment to Improve Patient Outcomes: Carl, Margret

Hospital Consultations in Hyponatremia: Appropriate Diagnosis and Effective Treatment to Improve Patient Outcomes
0.5 AMA PRA Category 1 Credit(s)™
Launch Date:
June 12, 2013
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

Alpesh N. Amin, MD, MBA, MACP, SFHM

Alpesh N. Amin, MD, MBA, MACP, SFHM
Activity Leader
Professor and Chair, Department of Medicine
Executive Director of the Hospitalist Program
University of California, Irvine
Irvine, California

Alpesh Amin, MD, MBA, MACP, SFHM, is with the University of California, Irvine (UCI) in the capacity of the Tom and Mary Cesario Chairman, Department of Medicine. He is Professor of Medicine, Business, Public Health and Nursing at UCI. He is also founder and executive director of the Hospitalist Program. Dr. Amin has served as Vice Chair for Clinical Affairs and Quality for 12 years, Chief of the Division of General Internal Medicine for 6 years, Associate Program Director of the Internal Medicine Residency Program for 14 years, and Medicine Clerkship Director for 14 years. Dr. Amin obtained his MD degree at Northwestern University Medical School in Chicago, Illinois, and later he completed his internship and his residencies in internal medicine, including a chief residency, at UCI. Also at UCI, he earned a healthcare MBA. Dr. Amin is the first hospitalist to be named Chairman of a Department of Medicine.
During the course of his career, Dr. Amin has served as principal investigator, co-investigator, and faculty sponsor on clinical trials and research projects focusing on clinical topics such as venous thromboembolism, pneumonia, and heart failure. His research interest is in health outcomes related to patient safety and quality improvement and medical education. He is a member of professional organizations as the Society of Hospital Medicine, (SHM) the American College of Physicians (ACP), the Society of General Internal Medicine, and Academic Chiefs and Leaders of General Internal Medicine (ALCGIM). He serves as ALCGIM's communication chair and is on the executive committee. Dr. Amin has authored or co-authored over 80 peer-reviewed articles. He is the co-editor/co-author of the Core Competencies for Hospital Medicine by SHM. He served as Chair of SHM's Education Committee for 4 years, the 2006 SHM Annual Meeting Course Director, and was on the SHM's Board of Directors. Dr. Amin was Associate Editor of Hospital Medicine Secrets. Dr. Amin is also co-editor of the book Contemporary Hospitalist Guide to Anticoagulation.
Dr. Amin's numerous awards and honors include the ACP's Special Recognition Award, a Masters of the ACP, named as one of "America's Top Physicians" by the Consumers' Research Council of America, Orange County Physician of Excellence Award, and ACP's Top 10 Hospitalist Award. Dr. Amin also is also the recipient of the 2010 Venous Research Award for Quality Improvement and Implementation of Best Practices from the Venous Disease Coalition/Vascular Disease Foundation.

Tomas Berl, MD

Tomas Berl, MD
Professor of Medicine
Division of Renal Diseases and Hypertension
University of Colorado
School of Medicine
Aurora, Colorado

Tomas Berl, MD, is Professor of Medicine in the Division of Renal Diseases and Hypertension at the University of Colorado School of Medicine and formerly was Head of the Division of Renal Diseases and Hypertension at the University of Colorado Health Science Center.
Dr. Berl earned his medical degree at New York University School of Medicine. He completed his internship at Albert Einstein College of Medicine, Bronx Municipal Hospital, in the Bronx, New York and his residencies at Albert Einstein College of Medicine, Bronx Municipal Hospital and the University of California School of Medicine in San Francisco. He went on to complete research fellowships in the Renal Division at the University of California School of Medicine and Cardiovascular Research Institute in San Francisco and the Division of Renal Diseases at the University of Colorado School of Medicine.
Board certified in internal medicine and nephrology, Dr. Berl is a fellow of the American College of Physicians and a member of the American Society of Nephrology (ASN), American Society for Clinical Investigation, American Association of Physicians, and the American Clinical and Climatological Association, among other professional societies. A past President of the ASN, he has served on many committees for both the ASN and the Association of Subspecialty Professors. He had continuous funding for his research from the National Institutes of Health for over 30 years. Dr. Berl has made numerous professional presentations on many topics including issues in the treatment of diabetic nephropathy and cardiac renal interactions and disorders of water balance, having authored or coauthored more than 110 original peer-reviewed articles and 80 book chapters in addition to more than 50 reviews and editorials.

Gary L. Robertson, MD

Gary L. Robertson, MD
Emeritus Professor of Medicine
Feinberg School of Medicine
Northwestern University
Chicago, Illinois

Dr. Robertson was born in Spokane, Washington and grew up in Coeur d'Alene, Idaho. After finishing public high school, he attended Harvard College and then Harvard Medical School. It was while at Harvard that his interest in medical research developed, particularly in the area of fluid and electrolyte disorders including hypernatremia, hyponatremia, diabetes insipidus (DI), and related diseases. From Harvard he went on to the National Institutes of Health (NIH) were he joined the effort in progress to develop an assay for vasopressin. That assay was successfully developed during his 2 years at the NIH. He took advantage of the unique opportunity this new tool offered and focused his investigative efforts in this area.
Dr. Robertson strongly feels that there is not enough emphasis being placed on the distinctions between the various forms of DI. While improved techniques for differential diagnosis of DI are available, they are not widely known and utilized. Without proper diagnosis, optimal treatment is not possible.
The most significant advance affecting the management of DI, in Dr. Robertson's opinion, was the development of an assay for plasma vasopressin as well as identification of the genes that encode the vasopressin prohormone, the V2 receptor, and the aquaporin water channels that mediate the antidiuretic effect of the hormone. The latter made possible the discovery of many genetic mutations responsible for the various types of familial DI, thereby improving diagnosis and offering the real possibility of developing better methods of treatment in coming decades.

When not in his lab, Dr. Robertson enjoys fly fishing, travelling, and opera. In fact, one of his reasons for choosing to work at University Hospitals in Chicago was the opportunity to attend the opera performances in the city.
1. Diagnose hyponatremia in hospitalized patients appropriately based on the presenting signs and symptoms and lab results
2. Incorporate  therapeutic agents that improve outcomes and minimize risk based on their ability to address the underlying pathophysiological problems in patients with hyponatremia